Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2016-09, Vol.51 (9), p.1265-1267
Hauptverfasser: Dourthe, M E, Ternès, N, Gajda, D, Paci, A, Dufour, C, Benhamou, E, Valteau-Couanet, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1267
container_issue 9
container_start_page 1265
container_title Bone marrow transplantation (Basingstoke)
container_volume 51
creator Dourthe, M E
Ternès, N
Gajda, D
Paci, A
Dufour, C
Benhamou, E
Valteau-Couanet, D
description
doi_str_mv 10.1038/bmt.2016.109
format Article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03830733v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A462664289</galeid><sourcerecordid>A462664289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-8cdb39b5338dee8c20ddf92ccca4f971f2a1c5d4cd97e282f60cdf6deed262153</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEoqWwY40sISGQyGA7d3ZDVSjSIDawjhzbSVwcO_jSYXa8Ay-IeBJOmKFqUYW8iM_Jd26_T5I8JnhFcFa_6qawopiUYDV3kmOSV2VaZGVxNznGtKzTLCubo-SB9xcYkzzHxf3kiFaEEJzT4-Tnm-ij7pn59f3HB6nnkWlmUG-1tlspULdDLAar7WCjRz7ICXGpNQqOGT8DGlhQ1iBl0Aw3aYJHWxVGNKphTJ3yX5CR0dlOMx_sxJB16GyrzIA8cxwcrxGUk99m66WAFqI53KFWFDskL5mOkBgCwigR18oozjRS08x4QLb_47ZOSLcYwsUBMTEB5aHFpbWHyb2eaS8fHb4nyee3Z59Oz9PNx3fvT9eblBekCmnNRZc1XZFltZCy5hQL0TeUc87yvqlITxnhhci5aCpJa9qXmIu-BFbQkpIiO0le7POCgu3s1MTcrrVMtefrTbv44K0yXGXZJQH2-Z6dnf0apQ_tpPyiKzMSdG5JTao6y3FTA_r0H_TCRmdgkpaWOaUFISX9H7Xkwk21b_FADUzLVpnegkZ8Kd2u85KWkK9ugFrdQsERclLcGtkr8N8IeHYtYJRMh9FbHRf1_U3w5R7kznrvZH-lE8Htssst7HK77DJYC_7kMFTsJimu4L_LC0C6Bzz8MoN016a-LeFvkO8Dtg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1817097215</pqid></control><display><type>article</type><title>Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration</title><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Dourthe, M E ; Ternès, N ; Gajda, D ; Paci, A ; Dufour, C ; Benhamou, E ; Valteau-Couanet, D</creator><creatorcontrib>Dourthe, M E ; Ternès, N ; Gajda, D ; Paci, A ; Dufour, C ; Benhamou, E ; Valteau-Couanet, D</creatorcontrib><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2016.109</identifier><identifier>PMID: 27111042</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/67/1059/99 ; 692/700/565/2194 ; Autografts ; Bone marrow ; Busulfan ; Care and treatment ; Cell Biology ; Drug interactions ; Ewing's sarcoma ; Hematology ; Human health and pathology ; Internal Medicine ; letter-to-the-editor ; Life Sciences ; Medicine ; Medicine &amp; Public Health ; Melphalan ; Methods ; Neuroblastoma ; Observations ; Patient outcomes ; Public Health ; Sarcoma ; Stem cell transplantation ; Stem Cells ; Transplantation</subject><ispartof>Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1265-1267</ispartof><rights>Macmillan Publishers Limited 2016</rights><rights>COPYRIGHT 2016 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 2016</rights><rights>Macmillan Publishers Limited 2016.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-8cdb39b5338dee8c20ddf92ccca4f971f2a1c5d4cd97e282f60cdf6deed262153</citedby><cites>FETCH-LOGICAL-c517t-8cdb39b5338dee8c20ddf92ccca4f971f2a1c5d4cd97e282f60cdf6deed262153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/bmt.2016.109$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/bmt.2016.109$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27111042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03830733$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dourthe, M E</creatorcontrib><creatorcontrib>Ternès, N</creatorcontrib><creatorcontrib>Gajda, D</creatorcontrib><creatorcontrib>Paci, A</creatorcontrib><creatorcontrib>Dufour, C</creatorcontrib><creatorcontrib>Benhamou, E</creatorcontrib><creatorcontrib>Valteau-Couanet, D</creatorcontrib><title>Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><subject>692/699/67/1059/99</subject><subject>692/700/565/2194</subject><subject>Autografts</subject><subject>Bone marrow</subject><subject>Busulfan</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Drug interactions</subject><subject>Ewing's sarcoma</subject><subject>Hematology</subject><subject>Human health and pathology</subject><subject>Internal Medicine</subject><subject>letter-to-the-editor</subject><subject>Life Sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melphalan</subject><subject>Methods</subject><subject>Neuroblastoma</subject><subject>Observations</subject><subject>Patient outcomes</subject><subject>Public Health</subject><subject>Sarcoma</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Transplantation</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kstu1DAUhiMEoqWwY40sISGQyGA7d3ZDVSjSIDawjhzbSVwcO_jSYXa8Ay-IeBJOmKFqUYW8iM_Jd26_T5I8JnhFcFa_6qawopiUYDV3kmOSV2VaZGVxNznGtKzTLCubo-SB9xcYkzzHxf3kiFaEEJzT4-Tnm-ij7pn59f3HB6nnkWlmUG-1tlspULdDLAar7WCjRz7ICXGpNQqOGT8DGlhQ1iBl0Aw3aYJHWxVGNKphTJ3yX5CR0dlOMx_sxJB16GyrzIA8cxwcrxGUk99m66WAFqI53KFWFDskL5mOkBgCwigR18oozjRS08x4QLb_47ZOSLcYwsUBMTEB5aHFpbWHyb2eaS8fHb4nyee3Z59Oz9PNx3fvT9eblBekCmnNRZc1XZFltZCy5hQL0TeUc87yvqlITxnhhci5aCpJa9qXmIu-BFbQkpIiO0le7POCgu3s1MTcrrVMtefrTbv44K0yXGXZJQH2-Z6dnf0apQ_tpPyiKzMSdG5JTao6y3FTA_r0H_TCRmdgkpaWOaUFISX9H7Xkwk21b_FADUzLVpnegkZ8Kd2u85KWkK9ugFrdQsERclLcGtkr8N8IeHYtYJRMh9FbHRf1_U3w5R7kznrvZH-lE8Htssst7HK77DJYC_7kMFTsJimu4L_LC0C6Bzz8MoN016a-LeFvkO8Dtg</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Dourthe, M E</creator><creator>Ternès, N</creator><creator>Gajda, D</creator><creator>Paci, A</creator><creator>Dufour, C</creator><creator>Benhamou, E</creator><creator>Valteau-Couanet, D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20160901</creationdate><title>Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration</title><author>Dourthe, M E ; Ternès, N ; Gajda, D ; Paci, A ; Dufour, C ; Benhamou, E ; Valteau-Couanet, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-8cdb39b5338dee8c20ddf92ccca4f971f2a1c5d4cd97e282f60cdf6deed262153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>692/699/67/1059/99</topic><topic>692/700/565/2194</topic><topic>Autografts</topic><topic>Bone marrow</topic><topic>Busulfan</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Drug interactions</topic><topic>Ewing's sarcoma</topic><topic>Hematology</topic><topic>Human health and pathology</topic><topic>Internal Medicine</topic><topic>letter-to-the-editor</topic><topic>Life Sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melphalan</topic><topic>Methods</topic><topic>Neuroblastoma</topic><topic>Observations</topic><topic>Patient outcomes</topic><topic>Public Health</topic><topic>Sarcoma</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dourthe, M E</creatorcontrib><creatorcontrib>Ternès, N</creatorcontrib><creatorcontrib>Gajda, D</creatorcontrib><creatorcontrib>Paci, A</creatorcontrib><creatorcontrib>Dufour, C</creatorcontrib><creatorcontrib>Benhamou, E</creatorcontrib><creatorcontrib>Valteau-Couanet, D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dourthe, M E</au><au>Ternès, N</au><au>Gajda, D</au><au>Paci, A</au><au>Dufour, C</au><au>Benhamou, E</au><au>Valteau-Couanet, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>51</volume><issue>9</issue><spage>1265</spage><epage>1267</epage><pages>1265-1267</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>27111042</pmid><doi>10.1038/bmt.2016.109</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1265-1267
issn 0268-3369
1476-5365
language eng
recordid cdi_hal_primary_oai_HAL_hal_03830733v1
source Springer Nature - Complete Springer Journals; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 692/699/67/1059/99
692/700/565/2194
Autografts
Bone marrow
Busulfan
Care and treatment
Cell Biology
Drug interactions
Ewing's sarcoma
Hematology
Human health and pathology
Internal Medicine
letter-to-the-editor
Life Sciences
Medicine
Medicine & Public Health
Melphalan
Methods
Neuroblastoma
Observations
Patient outcomes
Public Health
Sarcoma
Stem cell transplantation
Stem Cells
Transplantation
title Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A29%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Busulfan%E2%80%93Melphalan%20followed%20by%20autologous%20stem%20cell%20transplantation%20in%20patients%20with%20high-risk%20neuroblastoma%20or%20Ewing%20sarcoma:%20an%20exposed%E2%80%93unexposed%20study%20evaluating%20the%20clinical%20impact%20of%20the%20order%20of%20drug%20administration&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Dourthe,%20M%20E&rft.date=2016-09-01&rft.volume=51&rft.issue=9&rft.spage=1265&rft.epage=1267&rft.pages=1265-1267&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/bmt.2016.109&rft_dat=%3Cgale_hal_p%3EA462664289%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1817097215&rft_id=info:pmid/27111042&rft_galeid=A462664289&rfr_iscdi=true